Downloads
HB 5303 — Biomedical Research
by Health Care Appropriations Subcommittee and Rep. Garrison
This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.
Prepared by: Appropriations Committee (AP)
The bill relating to Biomedical Research, conforms law to the General Appropriations Act (GAA) for Fiscal Year 2023-2024. The bill:
- Expands those cancer centers eligible for funding pursuant to the Casey DeSantis Cancer Research Program (DeSantis program) to include cancer centers designated by the National Cancer Institute as a comprehensive cancer center with at least one geographic site in Florida.
- Adds qualified uses to cancer research funding.
- Exempts $37,771,257 from the annual allocation fraction calculation for participating cancer centers in the DeSantis program and distributes those funds to participating cancer centers using the proportion as determined by the calculation.
- Eliminates authorization for the endowed research chair contained within the Bankhead-Coley Cancer Research Program.
- Expands eligible programs for funding from the Biomedical Research Trust Fund to include “other cancer research initiatives as appropriated by the Legislature.”
- Adds breast cancer to the list of cancers to be included in the Department of Health’s tri-annual mortality rate and cancer research analysis report.
If approved by the Governor, or allowed to become law without the Governor’s signature, these provisions take effect July 1, 2023.
Vote: Senate 39-0; House 111-0